<DOC>
	<DOCNO>NCT00038415</DOCNO>
	<brief_summary>The goal clinical research study learn vaccine contain patient 's cancer cell immunoglobulin shrink slow growth Chronic Lymphocytic Leukemia ( CLL ) . This clinical trial dose escalation study safety vaccine study . This dose escalation study patient receive vaccine one dose level . Patients injected fragment Deoxyribonucleic acid ( DNA ) contain sequence immunoglobulin gene . Patients required diagnosis CLL stage confirm prior initiating vaccination . After vaccination patient receive clinical immunologic evaluation , include humoral cellular response . The investigator assess patient 's immune response whether patient 's body recognize DNA vaccine . In addition , side effect reaction vaccine evaluate .</brief_summary>
	<brief_title>A Phase I/II Trial Idiotypic Vaccination Chronic Lymphocytic Leukemia Using Genetic Approach</brief_title>
	<detailed_description>OBJECTIVES : 1 . To determine patient Binet Stage A CLL generate immune response antigen deliver DNA vaccine . 2 . To determine patient Binet Stage A CLL generate immune response tumor derive antigen deliver DNA vaccine . 3 . To determine optimal dose DNA vaccine obtain anti-idiotype immune response . 4 . To characterize adverse effect idiotypic vaccination DNA vaccine . 5 . To determine DNA idiotypic vaccination capable induce remission BinetÂ´s Stage A CLL .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Patients Binet Stage A Chronic Lymphocytic Leukemia ( CLL ) WHO performance status 2 le . A life expectancy least one year . Greater 18 year age . Availability CLL cell use DNA extraction processing . A platelet count great 100 x 109/l . Ability provide full informed consent . Previous chemotherapy radiotherapy . Presence monoclonal band serum electrophoresis . Presence clinically significant level antiDNA antibody , antimuscle antibody rheumatoid factor active autoimmune disease . Presence antibodies human immunodeficiency virus ( HIV ) know carrier hepatitis B hepatitis C virus . Presence serious medical condition e.g . congestive heart failure . Presence malignancy . Pregnancy , lactation , use contraceptive measure . Concurrent use anticancer therapy . Patients allergic tetanus vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Chronic Lymphocytic Leukemia</keyword>
	<keyword>CLL</keyword>
	<keyword>Binet Stage A</keyword>
	<keyword>Vaccination</keyword>
	<keyword>Idiotypic</keyword>
	<keyword>Genetic</keyword>
	<keyword>Deoxyribonucleic acid</keyword>
	<keyword>DNA</keyword>
</DOC>